Tricida Inc. (fka TCDAQ)

[kzivann]

Bounce again perhaps. In for a little.

TCDA

[Trend-Setter]

Elite Pharmaceuticals (otcqb: ELTP) = CASH FLOW POSITIVE for about 2 years now with low debt. Unbelievably suppressed stock price @ 3 cents. Year 2021 revenue is $32 Million. Income from Operations before taxes is $6.3 Million. Net income attributable to common shareholders is $8.9 Million. CEO owns 300 million shares. ELTP historically made couple of Millionaire-making monster runs.

Outstanding Shares: 1.01 Billion
Float : ~ 750 Million

Latest SEC 10-K Financial Report
https://www.sec.gov/ix?doc=/Archives/edgar/data/1053369/000149315222018108/form10-k.htm

ELTP primed for the next Millionaire Maker run!!!
2010-2011........................... $0.039- $0.26
2014...................................... $0.060- $0.97
2022-2023........................... $0.035- DollarLand?
Catalysts:
>>> First ever straight generic equivalent of oxycodone. No pharma company has entered the market yet to compete with Oxycodone as a generic.
>>> 2 abuse deterrents generic CNS stimulant
>>> ADF adderall

>>> Very rare to find an otc listed company with CASH FLOW POSITIVE status.

[Diego Delgado]

“Can This Be Salvaged?

To be blunt, there's virtually no future for Tricida. It went all-in on a single drug candidate and failed to deliver success. There's not much more that can be done at this point, which is why the company is being priced for insolvency.”

Maybe it bounces just off of people trading it.. who knows ..

$TCDA

[Diego Delgado]

https://www.thestreet.com/investing/this-biotech-lost-95-in-a-single-day-it-still-deserves-credit?puc=yahoo&cm_ven=YAHOO

$TCDA

[velcro]

Never mind, the CEO on the conference call is clueless on "unexpected results" and "no scientific explanation" and "different trial will not help"

[velcro]

All of a sudden, more posters with comments to influence price one way or the other?

[TheFinalCD]

Dumpster watching

Possible low spot. Watching

[TheFinalCD]

.58's

wondering if .50 will hold

[INFINITI]

Yes it is for the patience $$$$$

[bunda]

going lower today

[Pt3]

Chased .9 pick up please

[INFINITI]

Never know it’s all time low. Should go up j/s

[Pt3]

Why load is it dead cat bouncing

[Diego Delgado]

Grabbed a starter here! Lotto pick! $TCDA

[crudeoil24]

Hercules financial running for the hills > Tricida, Inc. (Nasdaq: TCDA) announced that it has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a leader in customizing debt financing for companies in the life sciences and technology-related markets. The total amount of the debt facility is $125 million of which $100 million will be available for drawdown at Tricida’s option subject to the achievement of certain milestones.

“As we prepare to report the topline results from the VALOR-CKD renal outcomes trial this month, we want to ensure we are positioned both financially and strategically to move toward a potential NDA resubmission, potential FDA approval and subsequent commercialization of veverimer,” said Geoff Parker, Chief Operating Officer and Chief Financial Officer of Tricida. “This debt facility provides us with additional flexibility in our future financing plans.”

[INFINITI]

Load up

[kzivann]

In for a little. May bounce after huge drop.

TCDA

[Jayplayer]

Relentless buying. They might hold it down till after hours.. this thing is gonna go tho

[INFINITI]

Load up the cheapies you won’t regret

[duderaja]

This stock has never been under 3.5 since it's inception as far as I can see and can't find any R/S. No brainer!

[Pt3]

Be over 1 soon

[ErnieBilco]

Me too how bad could it get after this drop?

[Pt3]

I'm in

[Whalatane]

From ClinicalTrials.gov Oct 13th

Primary Completion: August 23, 2022 [Actual]
Study Completion: September 27, 2022 [Actual]

Kiwi

[Whalatane]

While Venrock has been adding ...now a $100m position ...another hedge fund has been lowering their exposure

Insider Sell: Tricida
BY MT Newswires
— 7:22 AM ET 10/14/2022
07:22 AM EDT, 10/14/2022 (MT Newswires) -- Brian M. Isern, 10% Owner, on October 11, 2022, sold 360,000 shares in Tricida (TCDA) for $4,433,401.
Following the Form 4 filing with the SEC, Isern has control over a total of 3,340,143 shares of the company, with 3,340,143 controlled indirectly.
The market value of the direct and indirect holding, based on the transaction price, is approximately $40,048,315.

Kiwi

[Whalatane]

I think Venrock now has around $100m invested in TCDA .
Huge bet
If the P 3 trial fails … total bust … which I am not predicting…. Stock will trade for cash on hand ( rough guess $2-$3 a share )
Kiwi

[velcro]

TD Ameritrade is showing 100.65% Institutional Ownership which is worth a chuckle.
TCDA is going up while general market is going down.

[Whalatane]

Consistent insider buying by Venrock

On Monday, October 10th, Venrock Healthcare Capital Par bought 80,314 shares of Tricida stock. The stock was purchased at an average price of $11.89 per share, for a total transaction of $954,933.46.
On Monday, October 3rd, Venrock Healthcare Capital Par bought 268,736 shares of Tricida stock. The stock was purchased at an average price of $11.27 per share, for a total transaction of $3,028,654.72.
On Wednesday, September 28th, Venrock Healthcare Capital Par bought 76,600 shares of Tricida stock. The stock was purchased at an average price of $9.92 per share, for a total transaction of $759,872.00.
On Monday, September 26th, Venrock Healthcare Capital Par bought 395,614 shares of Tricida stock. The stock was purchased at an average price of $8.56 per share, for a total transaction of $3,386,455.84.
On Friday, July 29th, Venrock Healthcare Capital Par bought 18,900 shares of Tricida stock. The stock was purchased at an average price of $9.21 per share, for a total transaction of $174,069.00.
On Monday, July 25th, Venrock Healthcare Capital Par acquired 29,199 shares of Tricida stock. The shares were bought at an average price of $8.95 per share, for a total transaction of $261,331.05.
On Friday, July 22nd, Venrock Healthcare Capital Par acquired 15,000 shares of Tricida stock. The shares were bought at an average price of $9.21 per share, for a total transaction of $138,150.00.
On Wednesday, July 20th, Venrock Healthcare Capital Par acquired 25,000 shares of Tricida stock. The shares were bought at an average price of $9.54 per share, for a total transaction of $238,500.00.
On Monday, July 18th, Venrock Healthcare Capital Par acquired 100,000 shares of Tricida stock. The shares were bought at an average price of $9.02 per share, for a total transaction of $902,000.00.
On Thursday, July 14th, Venrock Healthcare Capital Par acquired 36,717 shares of Tricida stock. The shares were bought at an average price of $9.85 per share, for a total transaction of $361,662.45.
-----------------
Kiwi

[Whalatane]

Fidelity is showing 73% institutional , 11.6 % other ( which is retail ) and the rest funds and inside ( mgt )

Venrock HealthCare ...based in Palo Alto ... fairly close to TCDA HQ has been buying large over the past 4-6 wks .....adding around 2m shares for around $20 m total

Huge bet ...if this trial fails , Co will trade for cash on hand.

Currently COH is less then $98m ( cash plus short term instruments ) .......so expect a capital raise if the trial succeeds

Kiwi

[velcro]

Schwab is showing 98.48% Institutional Ownership.

[velcro]

Understood. Big Pharma runs happy TV ads and then mentions possible bad side effects.

[Whalatane]

It’s a binary event . Stock will crash if trial fails
However… 2 large insider buys in past 2 wks roughly and Oral presentations at Kidney wk are usually not reserved for clinical trials expected to fail .

Problem with existing med is patient adherence due to side effects .

Kiwi

[velcro]

Okay, thank you. I will continue to hold long.

[Whalatane]

Their drug treats Metabolic Acidosis . Low levels of blood bicarbonate causes metabolic acidosis that results in declining kidney function which can lead to need for dialysis and other severe health problems.
There are problems with the existing methods to treat this .

Not a chemist or MD but my wife is a Nephrology PA and treats CKD patients with metabolic acidosis

Kiwi

[velcro]

Any chemists or physicians who can speak to TCDA's function on the intestines to relieve the kidneys?
Is this similar to Renadyl which is a probiotic having the intestines reduce uremic toxins like creatinine, urea, and uric acid?

[interloper]

Looks to be waking up. Kind of surprised with the market action after them raising $42 mil.

[ClayTrader]

* * $TCDA Video Chart 10-30-2020 * *

Link to Video - click here to watch the technical chart video

[otcmoneydoubler]

TCDA LOOKS LIKE NEXT IN LINE TO RUN LIKE MARPS AND BLRX. WATCHING EQ AND UUU.

[Dubster watching]

Possible low spot. Watching